| Description: | One out of three people will undergo a molecular imaging exam in their lifetime. Thirty to 50 percent of disease treatments will be altered by molecular therapy. Doctors will be able to predict and prevent disease before symptoms appear. The impact molecular medicine will have on healthcare is unimaginable. Often called the “next frontier” of medicine, molecular imaging’s power comes from the fact that it goes well beyond looking at the body’s anatomy. Instead, it gets at the molecular causes of disease in order to provide preventative measures, and more predictable and better-monitored treatment. Essentially, healthcare is moving from treating the illness to treating the patient. Audiences will learn about the tools and technologies that will remove the guesswork from medicine, detect disease much earlier, provide new ways to monitor therapy to see if it’s working, and most importantly – create a healthcare system that saves both money and lives. |
| Expert: | Britta Fuenfstueck, CEO of Molecular Imaging[25 KB] Alex Zimmermann, Vice President, Global Sales and Marketing, Molecular Imaging[31 KB] |
If you're interested in securing a Siemens executive for a speaking engagement, please contact:
Mark Palacio
Computerized Physician Order Entry
Defining the Future State of Interoperability
Electronic Medical Records
Healthcare Industry Collaboration
How Technology Can Enhance Patient Safety
Medication Management
Staffing Shortages in Healthcare